logo
High-tech spectacle blends with science engagement – SHINE – BEYOND A SINGLE STORY

High-tech spectacle blends with science engagement – SHINE – BEYOND A SINGLE STORY

Business Mayor18-05-2025

Ti Gong
A huge humanoid robot waves hands in the virtual world while humanoid robots walk the red carpet in real world.
Humanoid robots strutted down a red carpet alongside scientists and tech leaders at the opening of the 2025 Shanghai Science Festival on Saturday, blending a high-tech spectacle with public science engagement.
Held at Zhangjiang Science Hall, the event spotlighted China's rapidly advancing robotics industry, positioning Shanghai as a showcase for emerging technologies including AI, XR, and humanoid automation.
Fourier's founder and CEO Gu Jie, and vice president Zeng Xiang, walked the carpet with two humanoid robots developed by the company: GR-2 and N1.
Jiang Xiaowei / SHINE
Fourier's founder and CEO Gu Jie (second from the left) and vice president Zeng Xiang (left) with two humanoid robots developed by the company.
The GR-2 stands 1.75 meters tall, weighs 63 kilograms, and is designed for heavy lifting and interactive training. It can carry more than 10 kilograms and is being developed for physical labor tasks across industries.
The smaller N1 model focuses on endurance, and is capable of running for more than two hours on a single charge. It is also fully open-source, with all blueprints and code publicly available, offering developers around the world a platform for collaboration and experimentation.
'When a 1.75-meter-tall robot walks alongside a human on the red carpet, it's not just for show. It's a glimpse into what's possible,' said Gu. 'These robots have undergone tens of thousands of hours of testing across various terrains and scenarios.'
Another crowd-pleasing moment came from Agibot's A2 robot, which performed a tai chi routine while explaining the martial art in real time. The 1.69-meter-tall robot moved with surprising fluidity, drawing applause from the audience.
Ti Gong
Agibot's humanoid robot plays tai chi on the red carpet.
'The pace of development is incredible,' said Wang Chuang, Agibot's general product line president. 'Last year, some robots still stumbled while walking. This year, they're performing. The red carpet is a perfect stage to show how fast we're advancing.'
The company has hundreds of humanoid robots deployed in real-world settings, with each unit produced on a standardized manufacturing line – 'ready to use, like a car,' he added.
This year's red carpet also featured an upgraded AI-powered experience using XR. As guests walked, their movements were merged live with dynamic virtual environments – from an immersive 'brain universe' to surreal, aurora-lit dreamscapes – each reflecting the creativity and innovation behind their work.
Ti Gong
A purple ocean where a huge whale is swimming appears at the site when Jo Quinton-Tulloch, director of the UK's National Science and Media Museum, and Ni Minjing, director of the Shanghai Science and Technology Museum, walk on the red carpet.
Ti Gong
Ni Minjing, director of the Shanghai Science and Technology Museum and Quinton-Tulloch, director of the UK's National Science and Media Museum.
The event drew a diverse crowd: top scientists, start-up founders, science influencers, and young inventors.
International guests included Jo Quinton-Tulloch, director of the UK's National Science and Media Museum, and Cho Sook-kyoung, president of the Network for the Public Communication of Science and Technology (PCST).
One emotional highlight saw neuroscientist Mu-Ming Poo and cell biologist Yuan Junying encounter AI-generated younger versions of themselves.
Yuan embraced her 18-year-old self and said: 'I want to tell my 18-year-old self that you've made the right choice. That's something I truly believe.'
Ti Gong
Xu Jian, deputy director of the university's School of Media and Communication, unveils the 'Global Urban Science Communication Capacity Index 2025.'
The report assessed 40 major cities across six continents, ranking New York first, followed by London and Boston. Other Chinese cities included Beijing (7th), Hong Kong (12th), Taipei (22nd), Shenzhen (23rd), Hangzhou (25th), and Guangzhou (26th).
The index mainly looks at how well research institutions, companies, governments, and media share and communicate science with the public.
New York leads by excelling across scientific outreach, organized communication, and public engagement. London and Boston follow closely, thanks to their vibrant scientific communities and diverse communication channels.
Shanghai's high ranking reflects rapid growth in science communication. It leads in offline public participation (1st), ranks fourth in media-driven outreach, and fifth in scientists' communication impact.
Zeng emphasized the PCST 2027's vision.
'We want this conference to bring science closer to everyday life,' he said.
'By building an innovative science communication network across the Yangtze River Delta, Shanghai aims to become a global hub for science communication and innovation.
'This will strengthen China's influence worldwide and inspire more people, especially youth, to engage with science and become future scientists.'
READ SOURCE

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Viridian Therapeutics to Participate in Upcoming June Investor Conferences
Viridian Therapeutics to Participate in Upcoming June Investor Conferences

Yahoo

timean hour ago

  • Yahoo

Viridian Therapeutics to Participate in Upcoming June Investor Conferences

WALTHAM, Mass., May 30, 2025--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today announced that members of its management team will participate in the following upcoming investor conferences: Jefferies Global Healthcare Conference (New York, NY): Presentation on Wednesday, June 4, at 7:35am ET Goldman Sachs 46th Annual Global Healthcare Conference 2025 (Miami, FL): Presentation on Monday, June 9, 2025 at 8:40am ET A live webcast of each presentation can be accessed under "Events and Presentations" on the Investors section of the Viridian website at A replay of the webcasts will be available following the completion of the event. About Viridian Therapeutics Viridian is a biopharmaceutical company focused on discovering, developing and commercializing potential best-in-class medicines for patients with serious and rare diseases. Viridian's expertise in antibody discovery and protein engineering enables the development of differentiated therapeutic candidates for previously validated drug targets in commercially established disease areas. Viridian is advancing multiple candidates in the clinic for the treatment of patients with thyroid eye disease (TED). The company is conducting a pivotal program for veligrotug (VRDN-001), including two global phase 3 clinical trials (THRIVE and THRIVE-2), to evaluate its efficacy and safety in patients with active and chronic TED. Both THRIVE and THRIVE-2 reported positive topline data, meeting all the primary and secondary endpoints of each study. Viridian is also advancing VRDN-003 as a potential best-in-class subcutaneous therapy for the treatment of TED, including two ongoing global phase 3 pivotal clinical trials, REVEAL-1 and REVEAL-2, to evaluate the efficacy and safety of VRDN-003 in patients with active and chronic TED. In addition to its TED portfolio, Viridian is advancing a novel portfolio of neonatal Fc receptor (FcRn) inhibitors, including VRDN-006 and VRDN-008, which has the potential to be developed in multiple autoimmune diseases. Viridian is based in Waltham, Massachusetts. For more information, please visit Follow Viridian on LinkedIn and X. View source version on Contacts IR@ Media@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Viridian Therapeutics to Participate in Upcoming June Investor Conferences
Viridian Therapeutics to Participate in Upcoming June Investor Conferences

Business Wire

timean hour ago

  • Business Wire

Viridian Therapeutics to Participate in Upcoming June Investor Conferences

WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today announced that members of its management team will participate in the following upcoming investor conferences: Jefferies Global Healthcare Conference (New York, NY): Presentation on Wednesday, June 4, at 7:35am ET Goldman Sachs 46th Annual Global Healthcare Conference 2025 (Miami, FL): Presentation on Monday, June 9, 2025 at 8:40am ET A live webcast of each presentation can be accessed under 'Events and Presentations' on the Investors section of the Viridian website at A replay of the webcasts will be available following the completion of the event. About Viridian Therapeutics Viridian is a biopharmaceutical company focused on discovering, developing and commercializing potential best-in-class medicines for patients with serious and rare diseases. Viridian's expertise in antibody discovery and protein engineering enables the development of differentiated therapeutic candidates for previously validated drug targets in commercially established disease areas. Viridian is advancing multiple candidates in the clinic for the treatment of patients with thyroid eye disease (TED). The company is conducting a pivotal program for veligrotug (VRDN-001), including two global phase 3 clinical trials (THRIVE and THRIVE-2), to evaluate its efficacy and safety in patients with active and chronic TED. Both THRIVE and THRIVE-2 reported positive topline data, meeting all the primary and secondary endpoints of each study. Viridian is also advancing VRDN-003 as a potential best-in-class subcutaneous therapy for the treatment of TED, including two ongoing global phase 3 pivotal clinical trials, REVEAL-1 and REVEAL-2, to evaluate the efficacy and safety of VRDN-003 in patients with active and chronic TED. In addition to its TED portfolio, Viridian is advancing a novel portfolio of neonatal Fc receptor (FcRn) inhibitors, including VRDN-006 and VRDN-008, which has the potential to be developed in multiple autoimmune diseases. Viridian is based in Waltham, Massachusetts. For more information, please visit Follow Viridian on LinkedIn and X.

Exclusive: Viture is teasing next-gen XR glasses — here's what we know about them
Exclusive: Viture is teasing next-gen XR glasses — here's what we know about them

Tom's Guide

time2 hours ago

  • Tom's Guide

Exclusive: Viture is teasing next-gen XR glasses — here's what we know about them

Viture already knocked it out of the park with its Pro XR glasses, and now it's teasing a new set of XR glasses — and they aim to deliver big upgrades to shake up the smart specs space. The next-gen XR glasses from Viture will be the first to use Sony's latest Micro-OLED panels, offering a sharper, brighter and wider field of view than we've seen in AR glasses to date. What's more, the specs will arrive with 6DoF (six degrees of freedom) for expanded, more realistic movement in a 3D space. It isn't just one pair of XR glasses either; Viture looks to launch multiple specs that will be "perfect" for everyone, meaning we may see different styles as with the selection of Ray-Ban Meta smart glasses. We've seen how the Viture Pro XR glasses propelled AR to new heights with its impressive display tech, making it one of the best smart glasses you can get. But it's next pair are already looking to bring more to the table, bringing spatial computing into focus. Let's dive into what we know. Just from the teaser images, we know the next-gen Viture XR glasses will sport a similar lightweight and premium design as with its previous specs, but this time with multiple stylings. It will also feature a camera on its frame not unlike the Ray-Ban Meta glasses or Snap Spectacles. This should bring spatial computing more into the fray. With 6DoF, you're getting full rotational movement of your body in a virtual environment, so the glasses are able to track your location and full motion. We've seen this in the Apple Vision Pro, Meta Quest 3 and even other smart glasses like the Xreal Air 2 Ultra. Get instant access to breaking news, the hottest reviews, great deals and helpful tips. However, Viture is bringing this support to more compact, everyday eyewear, and combining this with Sony's latest Micro-OLED panels means these specs may deliver a fully immersive mixed reality environment with sharper visuals and a much wider field of view (potentially even a bigger 135-inch virtual screen than its Pro XR glasses). There's still a lot to learn about Viture's upcoming specs, including its official release date and price, but there are a few predictions we can make that may come to light. For one, the XR glasses will "offer everything similar products do, but with many unique features and refinements others can't match." Thanks to Viture's SpaceWalker allowing for a multi-display setup right in the lenses, it already touches on how it can handle spatial computing. That said, if the specs are set to bring "unique features and refinements," we could see support for Android XR but with unique apps from Viture itself. Or, Viture may be cooking up some of its own tech to compete with Google's XR OS. Of course, this is still up in the air, but judging by how well the company has successfully combined its own software with its hardware, it's not out of the realm of belief. We're sure to learn more about Viture's next-gen XR glasses soon, and we hope to see stronger audio and a better viewing angle, too. With smart glasses edging closer to its next generational leap, especially in a mixed reality space, we'll be keeping a close eye on these upcoming specs.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store